Clinical Trials Directory

Trials / Unknown

UnknownNCT02623114

Attention-deficit/Hyperactivity Disorder Translational Center for Identifying Biomarkers

Comprehensive Pathophysiological Study Based on the Core Neurocognitive Deficits and Development of Biological Markers of Treatment Response in Attention Deficit Hyperactivity Disorder

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
400 (estimated)
Sponsor
Seoul National University Childrens Hospital · Academic / Other
Sex
All
Age
6 Years – 17 Years
Healthy volunteers
Accepted

Summary

The purpose of this study was to identify genetic, brain morphologic, and environmental biomarkers that contribute to the pathophysiology of attention-deficit/hyperactivity disorder (ADHD).

Detailed description

The investigators planned to recruit ADHD and healthy controls from the age of 6 to 17. Genetic data including dopamine, norepinephrine, serotonin, neurotropic factors, glutamate-related genes will be genotyped. Environmental disruptors including phthalate and cotinine will be analyzed. Brain MRI data including T1, diffusion tensor imaging (DTI), resting state functional MRI (rsfMRI) will be obtained. Neuropsychological tests including continuous performance test, Stroop test, Children's color trail test, Wisconsin card sorting test will be conducted. The investigators plan to identify biomarkers of ADHD using an integrative approach of genetic, environmental, neuroimaging and clinical data.

Conditions

Interventions

TypeNameDescription
DRUGmethylphenidateThe patients received a fixed dose of medication for 2 weeks. The dose was increased according to the clinician's judgment. The patients came to the hospital at week 2,4,6,8,16,24wks, 9, 12,15,18,21,24 months
DRUGatomoxetineThe patients received a fixed dose of medication for 2 weeks. The dose was increased according to the clinician's judgment. The patients came to the hospital at week 2,4,6,8,16,24wks, 9, 12,15,18,21,24 months

Timeline

Start date
2012-05-01
Primary completion
2016-08-01
Completion
2017-03-01
First posted
2015-12-07
Last updated
2015-12-07

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02623114. Inclusion in this directory is not an endorsement.